Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 828 across all filing types
Latest filing 2023-04-13 Declaration of Voting R…
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information relative au nombre d'actions et de droits de vote en date du 31 mars 2023" (Information relative to the number of shares and voting rights as of March 31, 2023). It explicitly references French regulatory articles (Code de Commerce and AMF Règlement Général) and provides a table detailing the total number of shares and gross/net voting rights as of a specific date. This type of periodic disclosure regarding capital structure and voting rights is a standard regulatory requirement, often falling under general regulatory announcements or specific share/capital change notifications. Since it is a formal announcement of a specific regulatory metric (voting rights calculation) rather than a comprehensive financial report (10-K, IR) or a general management discussion (MDA), it best fits the category for announcements related to share capital changes or general regulatory filings. Given the options, 'Share Issue/Capital Change' (SHA) is plausible if the change in rights is significant, but the core content is a mandatory disclosure of the current share count and voting rights, which is often categorized under general regulatory announcements or specific share disclosures. Since it is a formal, periodic disclosure mandated by the AMF regarding the capital structure (number of shares and voting rights), it aligns closely with 'Share Issue/Capital Change' (SHA) or potentially 'Regulatory Filings' (RNS). However, the content is specifically about the total number of shares and voting rights, which is a direct component of capital structure reporting. I will classify it as SHA as it directly reports on the capital base, although RNS is a close secondary option if SHA is interpreted too narrowly as only new issues/buybacks. Given the context of mandatory periodic reporting on the share count, SHA is the most specific fit among the choices that aren't general reports or meeting materials.
2023-04-13 French
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it is releasing the 'total number of outstanding shares as well as its voting rights as of February 28th, 2023,' pursuant to French commercial code and AMF regulations. This type of mandatory disclosure regarding share capital structure and voting rights is a specific regulatory filing. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). While it relates to capital structure, it is a mandatory disclosure of existing shares, not a new financing event (CAP) or a share repurchase (POS). It is a specific regulatory announcement concerning share capital/voting rights, which fits best under the general 'Regulatory Filings' (RNS) category as a specific type of mandatory disclosure not covered by other codes, or potentially related to 'Share Issue/Capital Change' (SHA) if interpreted broadly, but RNS is the safest general regulatory fallback for specific, non-standard disclosures. Given the context of mandatory disclosure under AMF rules regarding share count, RNS is the most appropriate general regulatory classification.
2023-03-17 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 28 février 2023" (Information relative to the number of shares and voting rights as of February 28, 2023). It explicitly states it is published in accordance with French commercial code (Code de Commerce) and AMF regulations (Autorité des Marchés Financiers). The core content is a table detailing the total number of shares and gross/net voting rights as of a specific date. This type of mandatory disclosure regarding capital structure changes or share counts, especially when triggered by specific events or required periodically by regulators like the AMF, often falls under general regulatory announcements or specific share/capital change notifications. Since it is a formal notification about the total number of shares and voting rights, it most closely aligns with 'Share Issue/Capital Change' (SHA) or, given its nature as a periodic regulatory disclosure not directly related to a dividend, earnings, or management change, it could be a general 'Regulatory Filing' (RNS). However, the content is specifically about the capital structure (number of shares and voting rights), making SHA a strong candidate. Given the options, 'SHA' (Share Issue/Capital Change) covers changes or updates to the capital base, which includes the total share count. If it were purely a notification of a threshold crossing, MRQ might apply, but this is a standard monthly disclosure of the total count. I will classify it as SHA as it directly reports on the capital composition.
2023-03-17 French
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 1% confidence The document explicitly states it announces the company's "résultats annuels 2022" (annual results for 2022) and provides a detailed, comparative IFRS income statement table for the full year ended December 31, 2022, against 2021. It also mentions that the annual consolidated accounts were approved by the board and that the audit is being finalized, which is typical for year-end reporting. Although it mentions the upcoming AGM, the core content is the detailed financial performance review for the entire fiscal year. This strongly indicates an Annual Report or a document closely associated with it, like an Earnings Release (ER) or Management Discussion & Analysis (MDA). Given the depth of the financial tables and the discussion of the full year's performance, it is more comprehensive than a typical ER. However, since the text states the audit is *in progress* and the accounts will be presented at the AGM, it functions as the primary disclosure of the annual financial results, fitting best under the scope of an Annual Report (10-K) or a very detailed Earnings Release/Interim Report. Since it covers the full year and includes comprehensive financial statements, it aligns most closely with the content expected in a 10-K, even if it's presented in a press release format. If a 10-K is not the exact format, the next best fit for comprehensive annual results disclosure is often an Earnings Release (ER) or Management Report (MDA). Given the detailed financial breakdown and the focus on the full year's performance, ER is a strong candidate, but MDA (Management's detailed explanation) also fits well. Since the document is titled 'résultats annuels 2022' and contains detailed financial tables, it is a comprehensive disclosure of annual results. In many contexts, this press release format summarizing the full year's audited/finalized results is classified as an Earnings Release (ER) or Management Discussion (MDA). Since it contains the full P&L summary and management commentary on the full year, MDA is highly appropriate, but ER is often used for the initial release of annual figures. Given the depth, I lean towards MDA or ER. I will select ER as it is the initial announcement of the annual figures, even if detailed. FY 2022
2023-03-15 French
Inside Information / News release on accounts, results
Earnings Release Classification · 1% confidence The document explicitly states it announces 'its annual results for 2022' and provides 'annual financial results as of December 31, 2022'. It includes a detailed financial table summarizing performance for the 'year ended December 31, 2022' compared to 2021, and discusses the 'Net loss of €6.9m in 2022'. This content strongly indicates a comprehensive annual financial report. Although it mentions the audit is being finalized and the statements will be presented at the AGM, the core content provided is the full annual financial performance summary, which aligns best with the Annual Report (10-K) definition, even if the company is European and might file a local equivalent. Since 10-K is the standard for comprehensive annual financial performance reporting in this classification system, it is the most appropriate fit over Interim Report (IR) or Earnings Release (ER). The document length is substantial (over 21k characters), ruling out RPA/RNS based on the 'MENU VS MEAL' rule. FY 2022
2023-03-15 English
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated February 15th, 2023, titled "Number of shares and voting rights of ADOCIA as of January 31st, 2023." It explicitly states that it is being released pursuant to the provisions of the French 'Code de Commerce' and the AMF charter (French stock-market authorities) to report the total number of outstanding shares and voting rights as of a specific date (January 31, 2023). This type of mandatory disclosure regarding share capital structure and voting rights is a specific regulatory filing requirement, often related to major shareholding notifications or capital structure updates. Among the provided codes, 'Major Shareholding Notification' (MRQ) is the closest fit for mandatory reporting of changes in the total number of shares and associated voting rights, although it is not strictly a notification of a *shareholder* crossing a threshold, but rather a mandatory periodic disclosure of the total count. Since it is a formal, periodic disclosure mandated by a financial regulator (AMF) concerning the capital structure, and it is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV), it fits best under the category related to significant ownership/capital structure changes or general regulatory reporting. Given the content focuses purely on the total share count and voting rights, it aligns most closely with the intent of 'Major Shareholding Notification' (MRQ) or potentially 'Regulatory Filings' (RNS) if MRQ is too specific. However, since it is a direct disclosure of the total share base, which underpins shareholding thresholds, MRQ is the most precise fit for this type of capital structure disclosure. The document length is short (4560 chars) but it is the primary disclosure, not an announcement of another document, so RPA/RNS fallback is not triggered based on the 'Menu vs Meal' rule.
2023-02-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.